Prolupin GmbH secured financing from the European Circular Bioeconomy Fund and other investors to accelerate growth and expand its plant-based product offerings in the European market.

Information on the Target

Prolupin GmbH, founded in 2015, has rapidly established itself in the plant-based food market with its vegan brand, Made with LUVE. The company's focus on lupine-based products has allowed it to experience significant annual growth, positioning Prolupin as a notable player in the bioeconomy sector. With this new round of financing, the company aims to tap into the mass market, facilitating further growth and international expansion.

Industry Overview in the Target’s Specific Country

The European plant-based food industry has been witnessing robust growth, driven by increasing consumer demand for healthier and more sustainable food options. The shift towards veganism and flexitarian diets has created a fertile environment for companies like Prolupin, which focus on innovative and sustainable products. As a result, the overall market for plant-based foods is projected to continue expanding, significantly impacting traditional dairy and food sectors.

Germany, in particular, has emerged as a leader in the European bioeconomy, being recognized for its advancements in sustainable agricultural practices and investments in green technologies. The German governm

View Source

Similar Deals

NPM Capital Elbfrost

2025

Growth Equity & Expansion Capital Frozen Food Manufacturing Germany
Vendis Capital BitterLiebe

2023

Growth Equity & Expansion Capital Drug Retailers (NEC) Germany
Q·CAPITAL VENTURES fresh five* premiumfood Ltd.

2023

Growth Equity & Expansion Capital Vegan & Vegetarian Food Manufacturing Germany
QC·VENTURES fresh five* premiumfood GmbH

2023

Growth Equity & Expansion Capital Special Foods & Wellbeing Products Germany
Odewald KMU Karl Schmidt GmbH

2023

Growth Equity & Expansion Capital Food Retail & Distribution (NEC) Germany
Project A WindStar Medical

2020

Growth Equity & Expansion Capital Retail - Drugs without Grocery Germany

European Circular Bioeconomy Fund

invested in

Prolupin

in 2023

in a Growth Equity & Expansion Capital deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert